125 related articles for article (PubMed ID: 21220491)
1. Prediction of colorectal cancer relapse and prognosis by tissue mRNA levels of NDRG2.
Chu D; Zhang Z; Li Y; Wu L; Zhang J; Wang W; Zhang J
Mol Cancer Ther; 2011 Jan; 10(1):47-56. PubMed ID: 21220491
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic silencing of NDRG2 promotes colorectal cancer proliferation and invasion.
Hong SN; Kim SJ; Kim ER; Chang DK; Kim YH
J Gastroenterol Hepatol; 2016 Jan; 31(1):164-71. PubMed ID: 26250123
[TBL] [Abstract][Full Text] [Related]
3. Suppression of N-myc downstream-regulated gene 2 is associated with induction of Myc in colorectal cancer and correlates closely with differentiation.
Shi H; Jin H; Chu D; Wang W; Zhang J; Chen C; Xu C; Fan D; Yao L
Biol Pharm Bull; 2009 Jun; 32(6):968-75. PubMed ID: 19483300
[TBL] [Abstract][Full Text] [Related]
4. Expression profile of the N-myc Downstream Regulated Gene 2 (NDRG2) in human cancers with focus on breast cancer.
Lorentzen A; Lewinsky RH; Bornholdt J; Vogel LK; Mitchelmore C
BMC Cancer; 2011 Jan; 11():14. PubMed ID: 21226903
[TBL] [Abstract][Full Text] [Related]
5. N-myc downstream-regulated gene 2 (NDRG2) promoter methylation and expression in pituitary adenoma.
Vaitkiene P; Valiulyte I; Glebauskiene B; Liutkeviciene R
Diagn Pathol; 2017 Apr; 12(1):33. PubMed ID: 28390436
[TBL] [Abstract][Full Text] [Related]
6. Tumor grade-related NDRG2 gene expression in primary and recurrent intracranial meningiomas.
Skiriute D; Tamasauskas S; Asmoniene V; Saferis V; Skauminas K; Deltuva V; Tamasauskas A
J Neurooncol; 2011 Mar; 102(1):89-94. PubMed ID: 20607352
[TBL] [Abstract][Full Text] [Related]
7. Analysis of RGS2 expression and prognostic significance in stage II and III colorectal cancer.
Jiang Z; Wang Z; Xu Y; Wang B; Huang W; Cai S
Biosci Rep; 2010 Dec; 30(6):383-90. PubMed ID: 20001967
[TBL] [Abstract][Full Text] [Related]
8. Decreased expression of SCUBE2 is associated with progression and prognosis in colorectal cancer.
Song Q; Li C; Feng X; Yu A; Tang H; Peng Z; Wang X
Oncol Rep; 2015 Apr; 33(4):1956-64. PubMed ID: 25672935
[TBL] [Abstract][Full Text] [Related]
9. Reduced N-Myc downstream-regulated gene 2 expression is associated with CD24 upregulation and poor prognosis in patients with lung adenocarcinoma.
Wang H; Wang W; Wang X; Cai K; Wu H; Ju Q; Huang Z; Gao X
Med Oncol; 2012 Dec; 29(5):3162-8. PubMed ID: 22528516
[TBL] [Abstract][Full Text] [Related]
10. Expression of NDRG2 is down-regulated in high-risk adenomas and colorectal carcinoma.
Lorentzen A; Vogel LK; Lewinsky RH; Saebø M; Skjelbred CF; Godiksen S; Hoff G; Tveit KM; Lothe IM; Ikdahl T; Kure EH; Mitchelmore C
BMC Cancer; 2007 Oct; 7():192. PubMed ID: 17935612
[TBL] [Abstract][Full Text] [Related]
11. [Expression and significance of new candidate tumor suppressor gene N-Myc downstream-regulated gene 2 in colorectal cancer].
Shi H; Wang WZ; Yao LB; Zhang J; Yin Q; Xu CS; Chu DK; Dong GL; Zhang HW; Li JP
Zhonghua Wei Chang Wai Ke Za Zhi; 2009 May; 12(3):281-4. PubMed ID: 19434539
[TBL] [Abstract][Full Text] [Related]
12. NDRG2 is involved in the oncogenic properties of renal cell carcinoma and its loss is a novel independent poor prognostic factor after nephrectomy.
Liang ZL; Kang K; Yoon S; Huang SM; Lim JS; Kim JM; Lim JS; Lee HJ
Ann Surg Oncol; 2012 Aug; 19(8):2763-72. PubMed ID: 22246425
[TBL] [Abstract][Full Text] [Related]
13. Expression of NDRG2 in human lung cancer and its correlation with prognosis.
Li SJ; Wang WY; Li B; Chen B; Zhang B; Wang X; Chen CS; Zhao QC; Shi H; Yao L
Med Oncol; 2013 Mar; 30(1):421. PubMed ID: 23307246
[TBL] [Abstract][Full Text] [Related]
14. Reduced expression of N-Myc downstream-regulated gene 2 in human thyroid cancer.
Zhao H; Zhang J; Lu J; He X; Chen C; Li X; Gong L; Bao G; Fu Q; Chen S; Lin W; Shi H; Ma J; Liu X; Ma Q; Yao L
BMC Cancer; 2008 Oct; 8():303. PubMed ID: 18940011
[TBL] [Abstract][Full Text] [Related]
15. Combined aberrant expression of N-Myc downstream-regulated gene 2 and CD24 is associated with disease-free survival and overall survival in patients with hepatocellular carcinoma.
Li B; Shao Q; Ji D; Li F; Guo X; Chen G
Diagn Pathol; 2014 Oct; 9():209. PubMed ID: 25338637
[TBL] [Abstract][Full Text] [Related]
16. KLF4 inhibits colorectal cancer cell proliferation dependent on NDRG2 signaling.
Ma Y; Wu L; Liu X; Xu Y; Shi W; Liang Y; Yao L; Zheng J; Zhang J
Oncol Rep; 2017 Aug; 38(2):975-984. PubMed ID: 28656310
[TBL] [Abstract][Full Text] [Related]
17. [Expression of candidate tumor suppressor gene N-Myc downstream-regulated gene 2 in colon cancer].
Chu DK; Zhang J; Shi H; Dong GL; Liu XP; Wang WZ
Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Jul; 11(4):354-7. PubMed ID: 18636358
[TBL] [Abstract][Full Text] [Related]
18. NDRG2 correlated with favorable recurrence-free survival inhibits metastasis of mouse breast cancer cells via attenuation of active TGF-β production.
Oh SS; Kim D; Kim DH; Chang HH; Sohn KC; Kim KH; Jung SH; Lee BK; Kim JH; Kim KD
Carcinogenesis; 2012 Oct; 33(10):1882-8. PubMed ID: 22696597
[TBL] [Abstract][Full Text] [Related]
19. Expression of the hMLH1 gene is a possible predictor for the clinical response to 5-fluorouracil after a surgical resection in colorectal cancer.
Ide T; Kitajima Y; Ohtaka K; Mitsuno M; Nakafusa Y; Miyazaki K
Oncol Rep; 2008 Jun; 19(6):1571-6. PubMed ID: 18497967
[TBL] [Abstract][Full Text] [Related]
20. Loss of the metastasis suppressor gene KiSS1 is associated with lymph node metastasis and poor prognosis in human colorectal cancer.
Okugawa Y; Inoue Y; Tanaka K; Toiyama Y; Shimura T; Okigami M; Kawamoto A; Hiro J; Saigusa S; Mohri Y; Uchida K; Kusunoki M
Oncol Rep; 2013 Sep; 30(3):1449-54. PubMed ID: 23784200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]